State of Wisconsin Investment Board’s Y-mAbs Therapeutics YMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-51,336
Closed -$232K 2546
2025
Q2
$232K Buy
+51,336
New +$231K ﹤0.01% 2159
2025
Q1
Sell
-37,857
Closed -$296K 2354
2024
Q4
$296K Sell
37,857
-17,811
-32% -$217K ﹤0.01% 2013
2024
Q3
$732K Buy
55,668
+14,461
+35% +$183K ﹤0.01% 1690
2024
Q2
$498K Buy
41,207
+6,204
+18% +$83.8K ﹤0.01% 1827
2024
Q1
$569K Sell
35,003
-41,900
-54% -$565K ﹤0.01% 1673
2023
Q4
$524K Sell
76,903
-24,800
-24% -$143K ﹤0.01% 1706
2023
Q3
$554K Buy
101,703
+900
+0.9% +$5.24K ﹤0.01% 1698
2023
Q2
$684K Sell
100,803
-49,997
-33% -$375K ﹤0.01% 1652
2023
Q1
$756K Buy
150,800
+23,242
+18% +$94.9K ﹤0.01% 1632
2022
Q4
$622K Buy
127,558
+50,741
+66% +$369K ﹤0.01% 1801
2022
Q3
$1.11M Sell
76,817
-22,277
-22% -$369K ﹤0.01% 1501
2022
Q2
$1.5M Buy
99,094
+6,994
+8% +$81.6K ﹤0.01% 1448
2022
Q1
$1.09M Buy
92,100
+51,100
+125% +$525K ﹤0.01% 1624
2021
Q4
$665K Hold
41,000
﹤0.01% 1587
2021
Q3
$1.17M Hold
41,000
﹤0.01% 1404
2021
Q2
$1.39M Hold
41,000
﹤0.01% 1363
2021
Q1
$1.24M Sell
41,000
-7,800
-16% -$320K ﹤0.01% 1318
2020
Q4
$2.42M Sell
48,800
-7,700
-14% -$356K 0.01% 1167
2020
Q3
$2.17M Buy
56,500
+7,200
+15% +$287K 0.01% 1152
2020
Q2
$2.13M Buy
49,300
+8,100
+20% +$306K 0.01% 1112
2020
Q1
$1.07M Buy
41,200
+10,600
+35% +$308K ﹤0.01% 1188
2019
Q4
$956K Hold
30,600
﹤0.01% 1253
2019
Q3
$797K Buy
30,600
+20,500
+203% +$524K ﹤0.01% 1187
2019
Q2
$231K Buy
+10,100
New +$232K ﹤0.01% 1474

Other funds holding YMAB

State of Wisconsin Investment Board's YMAB Position: Q3 2025 in Review

State of Wisconsin Investment Board sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 51,336 shares — an estimated $232K sold.

State of Wisconsin Investment Board first reported a position in YMAB in Q2 2019 and held it in 24 quarters. The position peaked at $2.42M in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.

  • State of Wisconsin Investment Board reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
  • State of Wisconsin Investment Board sold 51,336 Y-mAbs Therapeutics shares in Q3 2025, an estimated $232K.
  • State of Wisconsin Investment Board first reported a position in Y-mAbs Therapeutics in Q2 2019 and held it in 24 quarters.
  • State of Wisconsin Investment Board's Y-mAbs Therapeutics position peaked at $2.42M in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.

Based on State of Wisconsin Investment Board's 13F filing for Q3 2025, filed 14 Nov 2025.